PHB2 and breast carcinoma: Taken together, these findings suggest that BIG3 structurally overlays each KPNA binding region of PHB2, thereby blocking PHB2-KPNA interactions and resulting in the inhibition of E2-dependent PHB2 nuclear translocation in breast cancer cells (Fig 6).